Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients.

MLA

Tüysüz, Beyhan, et al. “Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients.” Cancers, vol. 15, no. 6, Mar. 2023, p. 1872. EBSCOhost, https://doi.org/10.3390/cancers15061872.

APA

Tüysüz, B., Bozlak, S., Uludağ Alkaya, D., Ocak, S., Kasap, B., Sunamak Çifçi, E., Seker, A., Bayhan, I. A., & Apak, H. (2023). Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients. Cancers, 15(6), 1872. https://doi.org/10.3390/cancers15061872

Chicago

Tüysüz, Beyhan, Serdar Bozlak, Dilek Uludağ Alkaya, Süheyla Ocak, Büşra Kasap, Evrim Sunamak Çifçi, Ali Seker, Ilhan Avni Bayhan, and Hilmi Apak. 2023. “Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients.” Cancers 15 (6): 1872. doi:10.3390/cancers15061872.